The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women**Supported in part by National Institutes of Health grant HD-17519-01A1.-Reference-Cited by-同舟云学术

The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women**Supported in part by National Institutes of Health grant HD-17519-01A1.

Published:1985-02 Issue:2 Volume:43 Page:200-205
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Lobo Rogerio A.,Shoupe Donna,Serafini Paulo,Brinton David,Horton Richard

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference21 articles.

1. New therapeutic approach to the hirsute patient;Boisselle;Fertil Steril,1979

2. A novel use of spironolactone: treatment of hirsutism;Shapiro;J Clin Endocrinol Metab,1980

3. Treatment of hirsutism with spironolactone;Cumming;JAMA,1982

4. Therapeutic effects of spironolactone in polycystic ovary syndrome;Milewicz;Obstet Gynecol,1983

5. Effect of spironolactone on sex hormones in man;Stripp;J Clin Endocrinol Metab,1974

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practise Updates: Diagnosis and Management of Idiopathic Hirsutism;Indian Journal of Endocrinology and Metabolism;2024-05

2. Potassium levels in women with polycystic ovary syndrome using spironolactone for long‐term;Clinical Endocrinology;2023-12-21

3. Diagnosis, pelvic pain, and medication mediate cognitive empathic abilities among women with endometriosis or polycystic ovary syndrome;Journal of Endometriosis and Pelvic Pain Disorders;2023-06

4. Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-02

5. Pathophysiology of Polycystic Ovarian Syndrome;Polycystic Ovary Syndrome - Functional Investigation and Clinical Application;2022-07-27